FINWIRES · TerminalLIVE
FINWIRES

Top Cryptocurrencies Fall; Bitcoin Drops Below $80,000

By

Top cryptocurrencies fell Wednesday, with Bitcoin (BTC-USD) falling below the $80,000 level.

The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, fell almost 1.4% in the past 24 hours. The Nasdaq 100 added 1.2%, the S&P 500 rose 0.8%, and the Dow Jones Industrial Average fell 0.1%.

Bitcoin fell 1.5% to $79,499, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume rose 6.1% to $33.76 billion.

Ethereum (ETH-USD), the second-largest digital asset by market value, fell 1.2% to $2,255.

XRP (XRP-USD) dropped 1.5%, BNB (BNB-USD) gained 1.3%, and Solana (SOL-USD) shed 4%. Dogecoin (DOGE-USD) rose 2.7%, and Cardano (ADA-USD) lost 3%.

The US 10-year Treasury yield stood at 4.478% at 3 p.m. ET Wednesday, up from 4.462% Tuesday, while the five-year yield rose to 4.128% from 4.122%.

The total market value of the cryptocurrency industry fell 1.3% in the past 24 hours to $2.66 trillion, with trading volume declining 1.4% to $161.06 billion.

Price: $79541.45, Change: $-932.53, Percent Change: -1.16%

What else is happening in Wire?

Wire

Gyre Therapeutics Says China Regulator Accepts Application for Liver Fibrosis Drug

Gyre Therapeutics Inc (GYRE) said China's regulator accepted its new drug application for F351, a treatment for chronic hepatitis B-induced liver fibrosis.The application, which received priority review status in March, marks "a significant milestone" in the program's path toward commercialization, the company said Tuesday in a statement.In the US, Gyre has completed a Phase 1 trial evaluating the drug's safety and tolerability in healthy volunteers and plans to file an investigational new drug application by the end of 2026, with a Phase 2 trial to follow if cleared.Gyre shares rose 1.4% in after-hours trading.

$GYRE
Wire

Evolution Petroleum Swings to Fiscal Q3 Loss as Revenue Falls; Shares Drop After Hours

Evolution Petroleum (EPM) reported a fiscal Q3 adjusted loss late Tuesday of $0.09 per diluted share, swinging from earnings of $0.02 a year earlier.Analysts polled by FactSet expected earnings of $0.02.Revenue in the three months ended March 31 fell to $20.2 million from $22.6 million a year earlier.Analysts surveyed by FactSet expected $21.3 million.Evolution shares fell 7.3% in after-hours trading.

$EPM
Wire

Arteris Q1 Adjusted Loss Narrows, Revenue Rises; Shares Gain After Hours; CFO to Retire

Arteris (AIP) reported a Q1 adjusted loss late Tuesday of $0.03 per diluted share, narrowing from the loss of $0.09 a year earlier.Four analysts polled by FactSet expected a loss of $0.07.Revenue in the three months ended March 31 rose to $22.9 million from $16.5 million a year earlier.Four analysts surveyed by FactSet expected $21 million.The company expects revenue of $23 million to $24 million in Q2 and $91 million to $95 million in the full year. Four analysts expect $22 million in Q2 and $91 million in the full year.Arteris shares rose 7.9% in after-hours trading.The company also said Chief Financial Officer Nicholas Hawkins plans to retire effective Aug. 31, and the board has started a search for a new CFO.

$AIP